Search Results - "Baryakh, E."

Experience in treatment of newly diagnosed multiple myeloma patients with renal failure required dialysis by Semochkin, S., Zhelnova, E., Misyurina, E., Tolstykh, T., Arkhipova, N., Baryakh, E., Grishina, E., Karimova, E., Kochneva, O., Mavrina, E., Polyakov, Y., Yaskova, E.

Get full text

PB2286: INFLUENCE OF ANTI‐CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID‐19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES by Zotina, E., Zhelnova, E., Karimova, E., Grishina, E., Paramonova, E., Gagloeva, D., Baryakh, E., Misyurina, E.

Get full text

PB1870: COVID ‐ 19 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: HOSPITAL MORALITY PREDICTORS by Kochneva, O., Baryakh, E., Misyurina, E., Zhelnova, E., Yatskov, K., Polyakov, Y., Kaluzhskaya, K., Chudnova, T., Tolstykh, T., Ivanova, D.

Get full text

P912: COVID19 SEVERITY AND THERAPEUTIC OPTIONS IN PATIENTS WITH MULTIPLE MYELOMA by Karimova, E., Zhelnova, E., Baryakh, E., Yatskov, K., Zotina, E., Grishina, E., Paramonova, E., Gagloeva, D., Misyurina, E.

Get full text

P1586: IN‐HOSPITAL MORTALITY AND POOR PROGNOSIS FACTORS ASSESSMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND COVID‐19 by Ivanova, D., Baryakh, E., Tolstykh, T., Chudnova, T., Polyakov, Y., Kochneva, O., Litvinenko, M., Misyurina, E., Yatskov, K.

Get full text

P1612: ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS: FEATURES OF TREATMENT IN CONTEXT OF THE COVID‐19 PANDEMIC by Tolstykh, T., Baryakh, E., Ivanova, D., Chudnova, T., Misyurina, M., Medvedovskaya, E., Litvinenko, M., Polyakov, Y., Kochneva, O.

Get full text

PB2272: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN HEMATOLOGICAL PATIENTS WITH 4 GRADE NEUTROPENIA AND CONCOMITANT CORONAVIRUS INFECTION by Kaluzskaya, K., Polyakov, Y., Baryakh, E., Gemdzhian, E., Misyurina, E., Zhelnova, E., Yatskov, K., Kochneva, O., Chudnova, T.

Get full text

PB2184: COURSE OF CORONAVIRUS INFECTION IN ONCOHEMATOLOGICAL PATIENTS IN THE POST‐TRANSPLANT PERIOD by Grishina, E., Gagloeva, D., Zhelnova, E., Karimova, E., Zotina, E., Paramonova, E., Baryakh, E., Misyurina, E.

Get full text

P363: TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA DURING COVID‐19 by Paramonova, E., Zhelnova, E., Misyurina, E., Baryakh, E., Karimova, E., Zotina, E., Grishina, E., Gagloeva, D., Lysenko, M.

Get full text

P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID‐19 by Chudnova, T., Baryakh, E., Polyakov, Y., Tolstykh, T., Kochneva, O., Ivanova, D., Misyurina, E., Yatskov, K., Zhelnova, E., Litvinenko, M., Kaluzhskaya, K.

Get full text

PB1853: IN‐HOSPITAL SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND CONCOMITANT CORONAVIRUS INFECTION DEPENDING ON VARIOUS CLINICAL FACTORS by Baryakh, E., Misyurina, E., Zhelnova, E., Yatskov, K., Kochneva, O., Polyakov, Y., Ivanova, D., Kaluzhskaya, K., Tolstykh, T., Chudnova, T., Samsonova, I., Lysenko, M.

Get full text

P1599: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND CONCOMITANT COVID‐19 INFECTION by Polyakov, Y., Kaluzhskaya, K., Baryakh, E., Gemdzhian, E., Misyurina, E., Zhelnova, E., Yatskov, K., Kochneva, O., Andreev, S., Chudnova, T., Ivanova, D., Tolstykh, T.

Get full text

BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A REAL WORLD SETTING: CLINICAL OUTCOMES AND IMPACT ON QUALITY OF LIFE by Ionova, T., Andrievskikh, M., Amdiev, A., Baryakh, E., Chang, V., Endakova, A., Fadeeva, N., Husainova, G., Ivanov, V., Kaplanov, K., Kaverina, O., Kiseleva, M., Klitochenko, T., Kurakin, V., Larionova, O., Lazareva, D., Lepik, K., Lysenko, I., Melnichenko, V., Mikhailova, N., Minullina, R., Mironov, O., Misyurina, E., Mochkin, N., Nikitina, T., Osipov, Y., Petrova, T., Porfirieva, N., Rukavitsyn, O., Safin, R., Samoylova, A., Shelekhova, T., Sherstnev, D., Simashova, P., Smirnova, E., Trenina, N., Vasiliev, E., Volodicheva, E.

Get full text

N-Terminal Fragment of Brain-Type Natriuretic Peptide (NT-proBNP) as a Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Complicated by Dialysis-Dependent Renal Failure by Semochkin, S. V., Misyurina, E. N., Zhelnova, E. I., Yurova, E. V., Gagloeva, D. E., Aref’eva, N. A., Ushakova, A. I., Kotenko, O. N., Tolstykh, T. N., Sinyavkin, D. O., Baryakh, E. A., Yatskov, K. V., Samsonova, I. V., Lysenko, M. A.

“…Prognostic value of N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) was analyzed in patients with multiple myeloma complicated…”
Get full text

The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data by Misyurina, A E, Kravchenko, S K, Kovrigina, A M, Magomedova, A U, Plastinina, L V, Obukhova, T N, Misyurin, A V, Misyurin, V A, Grebenuk, L A, Babaeva, F E, Baryakh, E A, Vorobiev, A I

“…Aim of the issue was to compare clinical characteristics and treatment results of patients with follicular lymphoma (FL) with translocations involving loci of…”
Get full text

TREATMENT OF RELAPSE AND REFRACTORY HODGKIN LYMPHOMA by Baryakh, E. A.

“…Hodgkin lymphoma (HL) represents one of the great success stories in hematology going from a uniformly fatal disease; to one that is curable in the vast…”
Get full text

COVID-19 in patients with acute lymphoblastic leukemia by Chudnova, T. S., Misyurina, E. N., Baryakh, E. A., Tolstykh, T. N., Shimanovskaya, L. T., Gagloeva, D. E., Zhelnova, E. I., Makeshova, A. B., Yatskov, K. V., Zotina, E. N., Ivanova, D. D., Mingalimov, M. A., Kochneva, O. L., Grishina, E. Yu, Yakimets, V. N.

“…Background. Patients with acute lymphoblastic leukemia (ALL) have been the most vulnerable group of patients at risk of severe and extremely severe COVID-19…”
Get full text

Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review by Mingalimov, M. A., Baryakh, E. A., Kochneva, O. L., Misyurina, E. N., Polyakov, Yu. Yu, Zhelnova, E. I., Yatskov, K. V., Makeshova, A. B., Tolstykh, T. N., Chudnova, T. S., Ivanova, D. D., Lebedev, D. V., Zotina, E. N., Gagloeva, D. E., Beregov, M. M., Mamatturdiev, E. A., Samsonova, I. V., Lysenko, M. A.

“…Diffuse large B-cell lymphoma is the most common immunomorphological variant of lymphoma in adults. Extranodal lesions are observed in a third of patients at…”
Get full text

Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2 by Polyakov, Yu. Yu, Baryakh, E. A., Misyurina, E. N., Zhelnova, E. I., Mingalimov, M. A., Kardovskaya, S. A., Smolyarchuk, M. Ya, Tolstykh, T. N., Chudnova, T. S., Ivanova, D. D., Kochneva, O. L., Lebedev, D. V., Abueva, A. U., Chistov, A. M., Zotina, E. N., Samsonova, I. V., Lysenko, M. A.

“…Treatment of immunocompromised patients with novel coronavirus infection (COVID-19) presents significant challenges. Currently, there are no unified approaches…”
Get full text

B-cell lymphoma, unclassifiable, intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma by Baryakh, E A, Misyurina, A E, Kovrigina, A M, Misyurin, V A, Kravchenko, S K

“…B-cell lymphoma that is unclassifiable and intermediate between diffuse large B-cell lymphoma (DLBCL) and Burkitt's lymphoma (BL)--(UBL) is an aggressive…”
Get full text